Oseltamivir (phosphate)
CAT:
804-HY-17016-03
Size:
500 mg
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No
Oseltamivir (phosphate)
- CAS Number: 204255-11-8
- UNSPSC Description: Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B.
- Target Antigen: Influenza Virus
- Type: Reference compound
- Related Pathways: Anti-infection
- Applications: COVID-19-anti-virus
- Field of Research: Infection; Cancer
- Assay Protocol: https://www.medchemexpress.com/Oseltamivir-phosphate.html
- Solubility: DMSO : 100 mg/mL (ultrasonic)|H2O : 100 mg/mL (ultrasonic)
- Smiles: O=C(OCC)C1=C[C@H]([C@@H]([C@H](C1)N)NC(C)=O)OC(CC)CC.OP(O)(O)=O
- Molecular Weight: 410.40
- References & Citations: [1]Huang H, et al. Transplacental transfer of Oseltamivir phosphate and its metabolite Oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population. J Matern Fetal Neonatal Med. 2016 Aug 8:1-5.|[2]de Oliveira JT, et al. Anti-influenza neuraminidase inhibitor Oseltamivir phosphate induces canine mammary cancer cell aggressiveness. PLoS One. 2015 Apr 7;10(4):e0121590.|[3]Li P, et al. A Simple and Robust Approach for Evaluation of Antivirals Using a Recombinant Influenza Virus Expressing Gaussia Luciferase. Viruses. 2018 Jun 13;10(6). pii: E325.Antiviral Res. 2020 Apr;176:104751. |Arch Pharm Res. 2018 Jun;41(6):664-676.|Bioeng Transl Med. 2020 Dec 1;6(1):e10196.|Biomed Pharmacother. 2018 Jan;97:385-394. |bioRxiv. 2023 Aug 12.|bioRxiv. 2024 May 8:2024.05.06.592815.|Biosci Biotechnol Biochem. 2020 Apr;84(4):774-779.|Cell Prolif. 2021 Jan;54(1):e12953.|Chemosphere. 2015 Jul;131:41-7.|Front Cell Dev Biol. 17 December 2021.|Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep.|Inflammation. 2023 Aug 21.|Int J Mol Sci. 2019 Dec 12;20(24):6261.|Int J Mol Sci. 2022 Apr 1;23(7):3940.|J Ethnopharmacol. 2023 Oct 6:117290.|J Med Virol. 2023 Jul;95(7):e28968.|Lab Invest. 2020 Dec;100(12):1602-1617.|Sci Rep. 2021 Aug 11;11(1):16293.|Signal Transduct Target Ther. 2021 Apr 24;6(1):165.|Virology. 2020 Jun;545:1-9.|Viruses. 2018 Jun 13;10(6). pii: E325. |Antiviral Res. 2016 Mar;127:68-78. |bioRxiv. 2024 July 07.|Food Funct. 2016 Apr 20;7(4):2052-9. |Int J Infect Dis. 2024 Jun 27:107134.|Phytochemistry. 2023 Aug 17;113829.|Phytomedicine. 2024 Mar 24, 155534.|SSRN. 2024 Aug 7.|Virol Sin. 2024 Aug 19:S1995-820X(24)00134-2.|Virology. 2023 Dec 2, 109954.|Virulence. 2024 Jan 3:2301242.
- Shipping Conditions: Room Temperature
- Clinical Information: Launched